Dr. Wilson, based in Tulsa and Oklahoma City, allegedly knowingly accepted significant payments from the pharmacy in exchange for recommending pain creams produced by the pharmacy.
The pharmacy paid Dr. Wilson what were characterized as “medical director fees” based on an hourly rate, but the suit alleges the fees were kickback payments, a violation of the False Claims Act.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
